Michael Gelband’s GeneDx Holdings WGS Stock Holding History

Michael Gelband’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Buy	+25,174	New	+$1.43M	0.01%	873
2022 Q2	–	Sell	-4,423	Closed	-$448K	–	2508
2022 Q1	$448K	Buy	4,423 +896	+25%	+$99.6K	0.01%	1597
2021 Q4	$519K	Buy	+3,527	New	+$788K	0.01%	1370
2021 Q1	–	Sell	-455	Closed	-$166K	–	2663
2020 Q4	$166K	Buy	+455	New	+$159K	﹤0.01%	1771

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Michael Gelband's WGS Position: Q2 2026 in Review

Michael Gelband opened a new position in GeneDx Holdings (WGS) in Q2 2026: 25,174 shares worth $1.73M. The stake represents 0.01% of the portfolio and ranks #873 among its holdings. This is a return to the name: Michael Gelband previously reported a position in WGS as recently as Q1 2022.

Michael Gelband first reported a position in WGS in Q4 2020 and has held it in 4 quarters since. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Michael Gelband held 25,174 shares of GeneDx Holdings worth $1.73M as of Q2 2026.
GeneDx Holdings was a new Michael Gelband position in Q2 2026.
GeneDx Holdings made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #873 holding.
Michael Gelband first reported a position in GeneDx Holdings in Q4 2020 and has held it in 4 quarters since.
222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.